/ /

  • linkedin
  • Increase Font
  • Sharebar

    DRCRnet Protocol S results provide evidence for retinopathy advance

    Las Vegas—Results from the Diabetic Retinopathy Clinical Research Network Protocol S provide evidence for the first major advance in the treatment of proliferative diabetic retinopathy (PDR) in more than 40 years, said Jeffrey Gross, MD.

    The results were reported for the first time at Retina 2015 and simultaneously published in the Journal of the American Medical Association, noted Dr. Gross, at the annual meeting of the American Academy of Ophthalmology.

    “Panretinal photocoagulation (PRP) is a time-tested treatment for PDR over the last four decades, and it remains effective today,” said Dr. Gross, founder and managing partner, Carolina Retina Center, Columbia, SC. “PRP substantially reduces the risk of severe vision loss, but it is inherently destructive, has other side effects, and it is not perfect because 5% of eyes have severe vision loss despite PRP.”

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results